Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement that it has submitted a new drug clinical trial application (IND) for ASC39 oral tablets to the US Food and Drug Administration (FDA). ASC39 Oral Tablet is an oral small molecule selective insulin receptor agonist used to treat obesity.

Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement that it has submitted a new drug clinical trial application (IND) for ASC39 oral tablets to the US Food and Drug Administration (FDA). ASC39 Oral Tablet is an oral small molecule selective insulin receptor agonist used to treat obesity.